Medications

FDA panel says no to experimental ALS drug

An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.

Diseases, Conditions, Syndromes

Multiple sclerosis: New approach for repairing damaged nerve sheaths

Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS). In Germany, more than 280,000 people are affected. In most cases, MS progresses in relapses, which occur completely irregularly ...

page 3 from 37